⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DFTX News
Definium Therapeutics, Inc. Common Shares
Form 8-K
sec.gov
DFTX
Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
businesswire.com
DFTX
Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
businesswire.com
DFTX
New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States
businesswire.com
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
businesswire.com
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
prnewswire.com
GHRS
HELP
DFTX
ATAI
CMPS
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
prnewswire.com
GHRS
DFTX
HELP
ATAI
LBRX
Form 8-K
sec.gov
DFTX